High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease

Gastroenterology

Volumn 127, Issue 2, 2004, Pages 412-421

  Darfeuille Michaud, Arlette ^a,f   Boudeau, Jérôme ^a   Bulois, Philippe ^b   Neut, Christel ^c   Glasser, Anne Lise ^a   Barnich, Nicolas ^a   Bringer, Marie Agnès ^a   Swidsinski, Alexander ^d   Beaugerie, Laurent ^e   Colombel, Jean Frédéric ^b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIV LILLE   (France)

^d HUMBOLDT UNIVERSITY   (Germany)

^e HÔPITAL SAINT ANTOINE   (France)

^f Lab des Maladies Metaboliques   (France)

Author keywords

adherent invasive Escherichia coli; AIEC; LB; Luria Bertani

Indexed keywords

ACTIN;

ACTIN FILAMENT; ADULT; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; CROHN DISEASE; DNA HYBRIDIZATION; ENTEROPATHY; ESCHERICHIA COLI; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM MUCOSA; INTESTINE EPITHELIUM CELL; MACROPHAGE; MALE; MICROTUBULE ASSEMBLY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; TISSUE SECTION; ULCERATIVE COLITIS;

EID: 4143069158     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.04.061     Document Type: Article

References (50)

1. Sartor R.B., Rath H.C., Sellon R.K. Microbial factors in chronic intestinal inflammation. Curr Opin Gastroenterol. 12:1996;327-333
2. Shanahan F. Crohn's disease. Lancet. 359:2002;62-69
3. Elson C.O. Commensal bacteria as targets in Crohn's disease. Gastroenterology. 119:2000;254-257
4. Podolsky D.K. Inflammatory bowel disease. N Engl J Med. 347:2002;417-429
5. Zumla A., James D.G. Granulomatous infections etiology and classification. Clin Infect Dis. 23:1996;146-158
6. Colombel J.F., Lemann M., Cassagnou M., Bouhnik Y., Duclos B., Dupas J.L., Notteghem B., Mary J.Y. A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Am J Gastroenterol. 94:1999;674-678
7. Greenbloom S.L., Steinhart A.H., Greenberg G.R. Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol. 12:1998;53-56
8. Turunen U.M., Farkkila M.A., Hakala K., Seppala K., Sivonen A., Ogren M., Vuoristo M., Valtonen V.V., Miettinen T.A. Long-term treatment of ulcerative colitis with ciprofloxacin a prospective, double-blind, placebo-controlled study. Gastroenterology. 115:1998;1072-1078
9. Prantera C., Zannoni F., Scribano M.L., Berto E., Andreoli A., Kohn A., Luzi C. An antibiotic regimen for the treatment of active Crohn's disease a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol. 91:1996;328-332
10. Rutgeerts P, Hiele M., Geboes K., Peeters M., Penninckx F., Aerts R., Kerremans R. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology. 108:1995;1617-1621
11. Sutherland L., Singleton J., Sessions J., Hanauer S., Krawitt E., Rankin G., Summers R., Mekhjian H., Greenberger N., Kelly M., Levine J., Thomson A., Alpert E., Prokipchuk E. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut. 32:1991;1071-1075
12. Rutgeerts P., Goboes K., Peeters M., Hiele M., Penninckx F., Aerts R., Kerremans R., Vantrappen G. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 338:1991;771-774
13. Neut C., Bulois P., Desreumaux P., Membre J.M., Lederman E., Gambiez L., Cortot A., Quandalle P., van Kruiningen H., Colombel J.F. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol. 97:2002;939-946
14. Tamboli C.P., Neut C., Desreumaux P., Colombel J.F. Dysbiosis in inflammatory bowel disease. Gut. 53:2004;1-4
15. Rath H.C., Wilson K.H., Sartor R.B. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun. 67:1999;2969-2974
16. Dieleman L.A., Goerres M.S., Arends A., Sprengers D., Torrice C., Hoentjen F., Grenther W.B., Sartor R.B. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut. 52:2003;370-376
17. Shanahan F. Probiotics in inflammatory bowel disease. Gut. 48:2001;48-609
18. Giaffer M.H., Holdsworth C.D., Duerden B.I. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut. 33:1992;646-650
19. Liu Y., van Kruiningen H.J., West A.B., Cartun R.W., Cortot A., Colombel J.F. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. [see comments] Gastroenterology. 108:1995;1396-1404
20. Darfeuille-Michaud A., Neut C., Barnich N., Lederman E., Di Martino P., Desreumaux P., Gambiez L., Joly B., Cortot A., Colombel J.F. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 115:1998;1405-1413
21. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M., Weber J., Hoffmann U., Schreiber S., Dietel M., Lochs H. Mucosal flora in inflammatory bowel disease. Gastroenterology. 122:2002;44-54
22. Fujimura Y., Kamoi R., Iida M. Pathogenesis of aphthoid ulcers in Crohn's disease correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut. 38:1996;724-732
23. Rickert R.R., Carter H.W. The "early" ulcerative lesion of Crohn's disease correlative light- and scanning electron-microscopic studies. J Clin Gastroenterol. 2:1980;11-19
24. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;603-606
25. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603
26. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., Foster S.J., Moran A.P., Fernandez-Luna J.L., Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem. 278:2003;5509-5512
27. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 278:2003;8869-8872
28. Hisamatsu T., Suzuki M., Reinecker H.C., Nadeau W.J., McCormick B.A., Podolsky D.K. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 124:2003;993-1000
29. Tieng V., Le Bouguenec C., du Merle L., Bertheau P., Desreumaux P., Janin A., Charron D., Toubert A. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U S A. 99:2002;2977-2982
30. Boudeau J., Glasser A.L., Masseret E., Joly B., Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun. 67:1999;4499-4509
31. Boudeau J., Barnich N., Darfeuille-Michaud A. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol. 39:2001;1272-1284
32. Glasser A.L., Boudeau J., Barnich N., Perruchot M.H., Colombel J.F., Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun. 69:2001;5529-5537
33. Rutgeerts P., Geboes K., Vantrappen G., Beyls J., Kerremans R., Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 99:1990;956-963
34. Barbut F., Beaugerie L., Delas N., Fossati-Marchal S., Aygalenq P., Petit J.C. Comparative value of colonic biopsy and intraluminal fluid culture for diagnosis of bacterial acute colitis in immunocompetent patients. Infectious Colitis Study Group. Clin Infect Dis. 29:1999;356-360
35. Levine M.M., Nataro J.P., Karch H., Baldini M.M., Kaper J.B., Black R.E., Clements M.L., O'Brien A.D. The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J Infect Dis. 152:1985;550-559
36. Evans D.G., Silver R.P., Evans D.J. Jr, Chase D.G., Gorbach S.L. Plasmid-controlled colonization factor associated with virulence in Escherichia coli enterotoxigenic for humans. Infect Immun. 12:1975;656-667
37. Le Bouguenec C., Garcia M.I., Ouin V., Desperrier J.M., Gounon P., Labigne A. Characterization of plasmid-borne afa-3 gene clusters encoding afimbrial adhesins expressed by Escherichia coli strains associated with intestinal or urinary tract infections. Infect Immun. 61:1993;5106-5114
38. Clerc P., Sansonetti P.J. Entry of Shigella flexneri into HeLa cells evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect Immun. 55:1987;2681-2688
39. Falkow S., Small P., Isberg R., Hayes S.F., Corwin D. A molecular strategy for the study of bacterial invasion. Rev Infect Dis. 9:(Suppl 5):1987;S450-S455
40. Darfeuille-Michaud A. Adherent-invasive Escherichia coli a putative new E. coli pathotype associated with Crohn's disease. Int J Med Microbiol. 292:2002;185-193
41. Klemm P., Schembri M.A. Bacterial adhesins function and structure. Int J Med Microbiol. 290:2000;27-35
42. Rhodes J.M. Unifying hypothesis for inflammatory bowel disease and associated colon cancer sticking the pieces together with sugar. Lancet. 347:1996;40-44
43. Geyid A., Fletcher J., Gashe B.A., Ljungh A. Invasion of tissue culture cells by diarrhoeagenic strains of Escherichia coli which lack the enteroinvasive inv gene. FEMS Immunol Med Microbiol. 14:1996;15-24
44. Dickinson R.J., Varian S.A., Axon A.T., Cooke E.M. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut. 21:1980;787-792
45. Kagnoff M.F., Eckmann L. Epithelial cells as sensors for microbial infection. J Clin Invest. 100:1997;6-10
46. Ahmad T., Tamboli C., Jewell D., Colombel J.F. Clinical relevance of advances in genetics and pharmacogenetics in inflammatory bowel diseases. Gastroenterology. 126:2004;1533-1549
47. Lala S., Ogura Y., Osborne C., Hor S.Y., Bromfield A., Davies S., Ogunbiyi O., Nunez G., Keshav S. Crohn's disease and the NOD2 gene a role for Paneth cells. Gastroenterology. 125:2003;47-57
48. Fellermann K., Wehkamp J., Herrlinger K.R., Stange E.F. Crohn's disease a defensin deficiency syndrome? Eur J Gastroenterol Hepatol. 15:2003;627-634
49. Wehkamp J., Harder J., Weichenthal M., Mueller O., Herrlinger K.R., Fellermann K., Schroeder J.M., Stange E.F. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 9:2003;215-223
50. Wehkamp J., Harder J., Weichenthal M., Schmid M., Noack F., Schlee M., Nuding S., Hohmann N., Schwab M., Schaffeler E., Stallmach A., Fritz P., Schroder J.M., Fellermann K., Stange E.F. Pathomechanism of Crohn's disease NOD2 (CARD15) mutation deficient mucosal antimicrobial peptide (defensin) expression. Gut. 35:(Suppl II):2003;A1